Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726151 · ClinicalTrials.gov registry record · NA
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 17,000
- Enrollment target
NCT03726151 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 17,000 participants.
The verdict
NCT03726151, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 17,000 participants
- Enrollment target
Study Summary
UCLA and Northeast Valley Health Center (NEVHC), a large, multi-site Federally Qualified Health Center (FQHC), are partnering to address underutilization of the prophylactic HPV vaccine among underserved, ethnic minority adolescents receiving care through FQHCs. We will use a cluster randomized 2x2 stepped-wedge factorial study design, implemented in seven NEVHC clinics, to compare the effectiveness of parent reminders (mailed and text), multi-component clinic system strategies, a combined intervention (parent reminders + clinic system strategies) and usual care on HPV vaccine series completion among NEVHC adolescent patients. FQHCs provide essential health care to underserved groups and have the infrastructure to sustain effective strategies to improve preventive care delivery. Therefore, study findings will be invaluable for informing future efforts to improve HPV vaccination at the population-level.
Interventions
- BEHAVIORAL Parent Reminders
- BEHAVIORAL Multicomponent clinic-system strategies
- BEHAVIORAL Combined Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,000 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03726151
The ClinicalTrials.gov registry entry for NCT03726151 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Parent Reminders is the first listed.
NCT03726151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03726151 about?
NCT03726151 is a clinical study titled "Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs". UCLA and Northeast Valley Health Center (NEVHC), a large, multi-site Federally Qualified Health Center (FQHC), are partnering to address underutilization of the prophylactic HPV vaccine among underserved, ethnic minority adolescents receiving care through FQHCs. We will use a cluster randomized 2x2 ...
What is the current status of trial NCT03726151?
This trial is currently completed. It is a NA study. The enrollment target is 17,000 participants. The study started on 2018-05-01. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT03726151?
The interventions under investigation include: Parent Reminders (BEHAVIORAL), Multicomponent clinic-system strategies (BEHAVIORAL), Combined Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT03726151?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.